Literature DB >> 9672337

Prevalence of Helicobacter pylori infection and gastric mucosal abnormalities in chronic pancreatitis.

G Manes1, J E Dominguez-Muñoz, A Hackelsberger, A Leodolter, A Rössner, P Malfertheiner.   

Abstract

OBJECTIVE: Chronic pancreatitis is often associated with abnormal gastric acid secretion. However, previous studies have taken into consideration neither the potential role of Helicobacter pylori (H. pylori) infection nor histological features of the gastric mucosa in this context. The aim of this study was to analyze the prevalence of H. pylori infection as well as the pattern of gastritis in patients with chronic pancreatitis.
METHODS: Forty patients with chronic alcoholic pancreatitis were included in the study: 40 patients with alcoholic liver cirrhosis and normal exocrine pancreatic function and 40 asymptomatic nonalcoholic subjects matched for age and sex used as control subjects. Endoscopy was performed in all patients, and five biopsy specimens from the antrum (three from the gastric body and two from the cardia) were taken for histological grading of gastritis and H. pylori assessment.
RESULTS: Prevalence of H. pylori infection was similar in subjects with chronic pancreatitis (38%), asymptomatic subjects (28%) and liver cirrhosis (30%). Topography and expression of H. pylori-associated chronic gastritis was also not different among the three groups of subjects. In H. pylori-negative subjects, the presence of moderate to severe chronic antral gastritis was significantly more common in patients with chronic pancreatitis (40%) than in subjects with liver cirrhosis (18%) and in asymptomatic subjects (14%) (p < 0.05). No difference was found among the three groups of patients with regard to gastritis activity, atrophy, and intestinal metaplasia in the various gastric regions. The chronicity grade of gastritis did not correlate with the severity of pancreatic insufficiency.
CONCLUSION: Prevalence of H. pylori infection is not different in patients with chronic pancreatitis as compared with subjects alcoholic liver cirrhosis and asymptomatic subjects. A severe H. pylori-negative chronic gastritis is more common in patients with chronic pancreatitis. This chronic inflammation of the gastric mucosa could contribute to determining the changes in gastric physiology described in patients with chronic pancreatitis.

Entities:  

Mesh:

Year:  1998        PMID: 9672337     DOI: 10.1111/j.1572-0241.1998.336_b.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis.

Authors:  V Savarino; G S Mela; P Zentilin; C Mansi; M R Mele; N Pandolfo; V Pugliese; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

3.  No evidence of Helicobacter pylori sequences in pancreatic juices of patients affected by chronic pancreatitis.

Authors:  C Di Campli; R Nocente; G Costamagna; N Gentiloni; R Burioni; J Wu; A Armuzzi; M A Zern; G Gasbarrini; A Gasbarrini
Journal:  Int J Pancreatol       Date:  2000-12

Review 4.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

5.  Linking gut microbiota with the human diseases.

Authors:  Udaya Kumar Vandana; Naseema Hayat Barlaskar; Abu Barkat Md Gulzar; Islamul Hoque Laskar; Diwakar Kumar; Prosenjit Paul; Piyush Pandey; Pranab Behari Mazumder
Journal:  Bioinformation       Date:  2020-02-29

Review 6.  Human Gut Microbiota and Gastrointestinal Cancer.

Authors:  Changting Meng; Chunmei Bai; Thomas D Brown; Leroy E Hood; Qiang Tian
Journal:  Genomics Proteomics Bioinformatics       Date:  2018-02-21       Impact factor: 7.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.